Safety and efficacy of the prostaglandin D2 receptor antagonist AMG 853 in asthmatic patients
Authors:
- William W. BusseWBWilliam W. Busse
- Sally E. WenzelSWSally E. Wenzel
- Eli O. MeltzerEMEli O. Meltzer
- Edward M. KerwinEKEdward M. Kerwin
- Mark C. LiuMLMark C. Liu
- Nan ZhangNZNan Zhang
- Yun ChonYCYun Chon
- Alison L. BudelskyABAlison L. Budelsky
- Joseph LinJLJoseph Lin
- Shao-Lee LinSLShao-Lee Lin
- 1 February 2013
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 131 (2) , 339-345
Abstract
No abstract availableKeywords
Funding Information
- Amgen
This publication has 21 references indexed in Scilit:
- Lebrikizumab Treatment in Adults with AsthmaNew England Journal of Medicine, 2011
- A randomized, double‐blind, placebo‐controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthmaClinical & Experimental Allergy, 2011
- Discovery of AMG 853, a CRTH2 and DP Dual AntagonistACS Medicinal Chemistry Letters, 2011
- Pharmacological Characterization of MK-7246, a Potent and Selective CRTH2 (Chemoattractant Receptor-Homologous Molecule Expressed on T-Helper Type 2 Cells) AntagonistMolecular Pharmacology, 2011
- Single-Dose, First-in-Human Study of AMG 853: Pharmacokinetics, Pharmacodynamics, and Safety in Healthy AdultsJournal of Allergy and Clinical Immunology, 2010
- Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitisJournal of Allergy and Clinical Immunology, 2009
- A prostaglandin D2receptor antagonist modifies experimental asthma in sheepClinical & Experimental Allergy, 2009
- CRTH2 antagonism significantly ameliorates airway hyperreactivity and downregulates inflammation-induced genes in a mouse model of airway inflammationAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Prostaglandin D 2 as a Mediator of Allergic AsthmaScience, 2000
- Development and validation of a questionnaire to measure asthma controlEuropean Respiratory Journal, 1999